Case Study: Rinvoq’s brand Dermatology market expansion strategy
Rinvoq is a selective and reversible JAK inhibitor that is being studied in several immune-mediated inflammatory diseases. Rinvoq is the brand of... Read More
Insight on USFDA approval of pralsetinib to treat non-small lung cancer
Blueprint Medicines Corporation, a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that the U.S.... Read More
Insight on First approved COVID-19 vaccine Sputnik V
Posted on11 Aug 2020
Comments0
Russia has announced the launch of first approved covid-19 vaccine. The Covid-19 vaccine brand name is Sputnik V. Sputnik V is developed... Read More
Zydus Cadila’s ZyCoV-D in Phase II clinical trials for COVID-19
Zydus Cadila’s ZyCoV-D is the plasmid DNA vaccine to prevent COVID-19. ZyCoV-D was found to be safe and well tolerated in the... Read More
Case analysis: Can marketing authorization can be revoked?
Yes. Marketing authorization can be revoked and it generally carried out, in case of safety issued observed with the molecule. Here is... Read More
Insight on USFDA Approves Vitrakvi® (larotrectinib), the First Ever TRK Inhibitor
Posted on29 Nov 2018
Comments0
The U.S. Food and Drug Administration (FDA) today approved Vitrakvi® (larotrectinib), the first ever oral TRK inhibitor, for the treatment of adult... Read More
Case Study: DCGI ordered the withdrawal of Voveran of Novartis
Posted on12 Jul 2018
TagsDCGI, diclofenac painkiller injection, Dynapar AQ, Product Recall, product withdrawal, themis, Transcutol-P, Voveran
Comments0
India’s drug regulator has ordered the withdrawal of the popular diclofenac painkiller injection marketed by Novartis India Ltd and made by Themis... Read More
Medical Science Liaison (MSL) – A Career Option for Healthcare Professionals !
What is The Medical Science Liaison (MSL)? The Medical Science Liaison (MSL) is a specific job related role within the healthcare industries, e.g.... Read More
NCK Pharma to introduce new edged “EMOTION BASED LEARNING” in the field of Pharmaceutical Learning
Bangalore (India), Press Release — NCK Pharma Solution Private Limited (popularly know as NCK), leading diversified training provider in the filed of... Read More
What is difference between phase IIa and Phase IIb clinical trial?
Posted on24 Jul 2016
Comments0
Phase II studies are sometimes divided into Phase IIA and Phase IIB. Phase IIA is specifically designed to assess dosing requirements (how... Read More